SCHEMBL285182

SCHEMBL285182

CCOc1[c]cccc1OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
L3MBTL1 Q9Y468 4/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GLA P06280 1/20 0.40
TDP1 Q9NUW8 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 1/20 0.36
HCRTR1 O43613 1/20 0.36
NQO1 P15559 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
PABPC1 P11940 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2A6 P11509 1/20 0.35
GRK6 P43250 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16959069 0.89 L3MBTL1 (0.40) ALDH1A1L3MBTL1MAPTNPSR1TDP1
SCHEMBL2461793 0.88 ALDH1A1 (0.42) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL314855 0.88 CA1 (0.39) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL17046287 0.86 L3MBTL1 (0.41) ALDH1A1L3MBTL1MAPTNPSR1TDP1
SCHEMBL17046322 0.84 L3MBTL1 (0.36) ALDH1A1L3MBTL1MAPTTDP1CYP1A2
SCHEMBL16951554 0.83 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL16959286 0.83 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL11128545 0.83 ALDH1A1 (0.39) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL16956116 0.82 ALDH1A1 (0.38) ALDH1A1L3MBTL1MAPTNPSR1GLA
SCHEMBL15352492 0.82 ALDH1A1 (0.34) ALDH1A1L3MBTL1TDP1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 621 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117831652-A Prediction method of olefin hydroformylation positive-to-negative ratio 上海华谊控股集团有限公司 2024-04-05 CN claimed
CN-114206886-B Gold (III) compound, method for preparing the same, and organic light emitting device using the same 广东聚华印刷显示技术有限公司 2024-02-27 CN claimed
EP-3575281-B1 DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED WINGO TECH CO LTD (JP) 2023-08-23 EP claimed
CN-114206886-A Luminescent gold (III) compound, method for preparing same, and organic light emitting device using same 广东聚华印刷显示技术有限公司 2022-03-18 CN claimed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 US claimed
WO-2021016814-A1 LUMINESCENT GOLD (III) COMPOUND, METHOD FOR PREPARING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-02-04 WO claimed
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 EP claimed
EP-3428202-A1 PROCESS OF PRODUCING POLYOLEFINS USING METALLOCENE POLYMERIZATION CATALYSTS AND COPOLYMERS THEREFROM ExxonMobil Chemical Patents Inc. (US) 2019-01-16 EP claimed
US-9862691-B2 Cyclic triazo and diazo sodium channel blockers UNIVERSITY OF GREENWICH (GB) 2018-01-09 US claimed
CN-105263969-B Using metallocene polymerization catalyst preparation polyolefin and the method for copolymer 埃克森美孚化学专利公司 2017-04-05 CN claimed
EP-0699200-B1 DIHALOTRIAZOLOPYRIMIDINE DERIVATIVES AS FUNGICIDES SHELL INT RESEARCH (NL) 1997-10-29 EP claimed
US-5612345-A Dihalotriazolopyrimidine derivatives as fungicides SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1997-03-18 US claimed
EP-0699200-A1 DIHALOTRIAZOLOPYRIMIDINE DERIVATIVES AS FUNGICIDES SHELL INT RESEARCH (NL) 1996-03-06 EP claimed
WO-1994020501-A1 DIHALOTRIAZOLOPYRIMIDINE DERIVATIVES AS FUNGICIDES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1994-09-15 WO claimed
EP-0133248-B1 1,2,4-TRIAZOL-1-YL-DERIVATIVES SHIONOGI & CO., LTD. (JP) 1991-11-21 EP claimed
EP-0162208-B1 NOVEL N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1989-11-23 EP claimed
EP-0067105-B1 ALLYL AMINE MAO INHIBITORS MERRELL DOW FRANCE ET CIE (FR) 1987-09-23 EP claimed
US-4683234-A HYPOTENSIVE AGENTS, ANTI-ANGINA SUNTORY LIMITED (JP) 1987-07-28 US claimed
EP-0162208-A2 Novel N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1985-11-27 EP claimed
EP-0067105-A2 Allyl amine MAO inhibitors MERRELL DOW FRANCE ET CIE (FR) 1982-12-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 ALDH1A1 1413/4885L3MBTL1 4015/4885MAPT 4739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.